Seeking cooperation with Japan in the pharmaceutical sector, India today said it is rebranding itself as the pharmacy to the world.
Commerce Secretary Rajeev Kher, who is in Tokyo, said that "India is rebranding itself as not only the pharmacy to the world, but also the responsible health care giver to the world."
Kher said that Indian medicines are affordable and of top quality as it meets the requirement of the toughest regulatory markets in the US and EU.
"India is doing cutting edge work in biologics and biotechnology as well as nanotechnology. In terms of drug discovery and R&D spend, India figures amongst world's top three countries," an official statement quoting Kher said.
The Secretary said there is a win-win possibility for both India and Japan in pharma cooperation.
Kher was in Tokyo for the India Show. About 120 pharma exhibitors are showcasing their products in one the biggest pharma products show in the world.
He also addressed the 27th International Pharmaceutical R&D and Manufacturing Expo/Conference.
Former Ficci president Habil Khorakiwala said Indian corporates are leading R&D spenders, with USD 5 billion being earmarked for the year 2014-15.
The pharma show will end on July 4.
